hVIVO PLC (OPORF)
0.1096
0.00 (0.00%)
USD |
OTCM |
Aug 25, 16:00
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 75.30M |
| 52 Week High (Daily) | |
| 52 Week Low (Daily) | |
| All-Time High (Daily) | |
| Year to Date Total Returns (Daily) | |
| 1 Month Total Returns (Daily) | |
| 1 Year Total Returns (Daily) | -54.33% |
| Valuation | |
| PE Ratio | -- |
| PE Ratio (Forward) | |
| PS Ratio | 1.220 |
| Price to Book Value | -- |
| EV to EBITDA | |
| Dividend | |
|---|---|
| Dividend | -- |
| Dividend Yield (Forward) | |
| Financials | |
| Revenue (5 Year Growth) | |
| Revenue (Quarterly YoY Growth) | |
| EPS Diluted (5 Year Growth) | |
| EPS Diluted (Quarterly YoY Growth) | |
| Debt to Equity Ratio | -- |
| Return on Equity | |
| Return on Assets | |
| Risk | |
| Beta (5Y) | |
| Max Drawdown (5Y) | 83.47% |
Profile
| hVIVO plc engages in the provision of end-to-end clinical services supporting drug development from pre-clinical to Phase II and beyond. It provides medical and scientific research services. The firm provides consulting, clinical trials, human challenge trials, and laboratory services. The company was founded on February 1, 2011 and is headquartered in London, the United Kingdom. |
| URL | http://www.hvivo.com |
| Investor Relations URL | N/A |
| HQ State/Province | Greater London |
| Sector | Health Care |
| Industry | Life Sciences Tools & Services |
| Equity Style | Small Cap Core |
| Next Earnings Release | N/A |
| Last Earnings Release | N/A |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | May. 16, 2025 |
Profile
| hVIVO plc engages in the provision of end-to-end clinical services supporting drug development from pre-clinical to Phase II and beyond. It provides medical and scientific research services. The firm provides consulting, clinical trials, human challenge trials, and laboratory services. The company was founded on February 1, 2011 and is headquartered in London, the United Kingdom. |
| URL | http://www.hvivo.com |
| Investor Relations URL | N/A |
| HQ State/Province | Greater London |
| Sector | Health Care |
| Industry | Life Sciences Tools & Services |
| Equity Style | Small Cap Core |
| Next Earnings Release | N/A |
| Last Earnings Release | N/A |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | May. 16, 2025 |